T@80 Evaluation
NHS England · awarded 6 March 2025 · delivered in England
Who
| Buyer | NHS England Leeds |
|---|---|
| Supplier |
RAND Europe Community Interest Company |
| Category | services |
| Classification | Health services CPV 85100000 |
| Notice published | 3 April 2025 |
What it is for
To support achievement of NHS Long Term Plan ambitions, it has been agreed by NHS England that the NHS Bowel Cancer Screening Programme referral threshold will reduce from 120 ug/gm to 80ug/gm, in line with the Scottish screening programme. Evidence suggests that this will be a cost-effective way to detect more cancers earlier, reduce mortality and increase quality of life. Achieving this extension will be challenging alongside year-on-year increases in endoscopy demand from symptomatic services, BSCP age extension, and the enrolment of people with Lynch syndrome into the programme. Therefore, to understand how this change in screening protocol can be delivered sustainably it has been agreed that the threshold will initially be dropped in select pilot sites alongside a comprehensive evaluation. Therefore NHSE seeks a partner to deliver the evaluation.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
1269 awards on file, worth £50.2bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
Everything NHS England has awarded →
Other contracts won by this supplier
22 awards on file, worth £14.1m.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 12 Jul 2024 | Research and Evaluation FrameworkEngland | Care Quality Commission | TONIC CONSULTANTS LIMITED +43 | £6.7m |
| 27 Oct 2024 | UKRI-3994 Metascience: Using Research to Transform ScienceSouth West | UK Research & Innovation | RAND Europe Community Interest Company | £3.0m |
| 25 Oct 2024 | Evaluation of the New Prisons Programme | Ministry of Justice | RAND Europe Community Interest Company | £872k |
| 23 Jan 2025 | Prj_3986 - Human Uplift Studies (HUS)London | DSIT | RAND Europe Community Interest Company | £693k |
| 6 Mar 2025 | T@80 EvaluationEngland | NHS England | RAND Europe Community Interest Company | £500k |